BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28352396)

  • 1. Qualitative Perfusion Cardiac Magnetic Resonance Imaging Lacks Sensitivity in Detecting Cardiac Allograft Vasculopathy.
    Colvin-Adams M; Petros S; Raveendran G; Missov E; Medina E; Wilson R
    Cardiol Res; 2011 Dec; 2(6):282-287. PubMed ID: 28352396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.
    DeSa TB; Abbasi MA; Blaisdell JA; Lin K; Collins JD; Carr JC; Markl M
    Clin Imaging; 2020 May; 61():62-68. PubMed ID: 31981959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Real-Time Myocardial Contrast Echocardiography to Detect Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Fine NM; Greenway SC; Mulvagh SL; Huang R; Maxon SA; Hepinstall MJ; Anderson JH; Johnson JN
    J Am Soc Echocardiogr; 2021 May; 34(5):503-510. PubMed ID: 33359634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy.
    Bravo PE; Bergmark BA; Vita T; Taqueti VR; Gupta A; Seidelmann S; Christensen TE; Osborne MT; Shah NR; Ghosh N; Hainer J; Bibbo CF; Harrington M; Costantino F; Mehra MR; Dorbala S; Blankstein R; Desai A; Stevenson L; Givertz MM; Di Carli MF
    Eur Heart J; 2018 Jan; 39(4):316-323. PubMed ID: 29236988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac allograft vasculopathy after heart transplantation: electrocardiographically gated cardiac CT angiography for assessment.
    Mittal TK; Panicker MG; Mitchell AG; Banner NR
    Radiology; 2013 Aug; 268(2):374-81. PubMed ID: 23657888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy.
    Sade LE; Eroğlu S; Yüce D; Bircan A; Pirat B; Sezgin A; Aydınalp A; Müderrisoğlu H
    J Am Soc Echocardiogr; 2014 May; 27(5):531-9. PubMed ID: 24613313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging.
    Prasad P; Nagappan R; Davidson BP; Wei K; Hodovan J; Lindner JR; Steiner J
    ESC Heart Fail; 2023 Oct; 10(5):3184-3189. PubMed ID: 37401366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials.
    Wever-Pinzon O; Romero J; Kelesidis I; Wever-Pinzon J; Manrique C; Budge D; Drakos SG; Piña IL; Kfoury AG; Garcia MJ; Stehlik J
    J Am Coll Cardiol; 2014 May; 63(19):1992-2004. PubMed ID: 24681148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of dobutamine stress echocardiography in the detection of cardiac allograft vasculopathy in heart transplant recipients: A systematic review and meta-analysis study.
    Elkaryoni A; Abu-Sheasha G; Altibi AM; Hassan A; Ellakany K; Nanda NC
    Echocardiography; 2019 Mar; 36(3):528-536. PubMed ID: 30726558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy.
    Braggion-Santos MF; Lossnitzer D; Buss S; Lehrke S; Doesch A; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1125-32. PubMed ID: 24908664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular dilation and functional impairment assessed by gated SPECT are indicators of cardiac allograft vasculopathy in heart transplant recipients.
    Wenning C; Stypmann J; Papavassilis P; Sindermann J; Schober O; Hoffmeier A; Scheld HH; Stegger L; Schäfers M
    J Heart Lung Transplant; 2012 Jul; 31(7):719-28. PubMed ID: 22425234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cardiac allograft vasculopathy by multidetector computed tomography and whole-heart magnetic resonance coronary angiography.
    Nunoda S; Machida H; Sekikawa A; Shitakura K; Okajima K; Kubo Y; Ueno E; Otsuka K
    Circ J; 2010 May; 74(5):946-53. PubMed ID: 20215697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft vasculopathy in Dutch heart transplant recipients.
    Galli G; Caliskan K; Balk AH; van Domburg R; Birim O; Salerno-Uriarte J; Manintveld OC; Constantinescu AA
    Neth Heart J; 2016 Dec; 24(12):748-757. PubMed ID: 27586194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging.
    Caus T; Kober F; Marin P; Mouly-Bandini A; Quilici J; Métras D; Cozzone PJ; Bernard M
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):45-9. PubMed ID: 16343922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low clinical utility of routine angiographic surveillance in the detection and management of cardiac allograft vasculopathy in transplant recipients.
    Clague JR; Cox ID; Murday AJ; Charokopos N; Madden BP
    Clin Cardiol; 2001 Jun; 24(6):459-62. PubMed ID: 11403507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated With Allograft Vasculopathy: Intracoronary Measurement Validation.
    Mirelis JG; García-Pavía P; Cavero MA; González-López E; Echavarria-Pinto M; Pastrana M; Segovia J; Oteo JF; Alonso-Pulpón L; Escaned J
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):571-8. PubMed ID: 25522835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Coronary Allograft Vasculopathy with Cardiac PET and Cardiac MRI.
    Madamanchi C; Konerman MC; Murthy VL
    Curr Cardiol Rep; 2021 Oct; 23(12):175. PubMed ID: 34657220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.